Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Dementia to Affect 10% of Elderly Citizens in 2036: Expert
September 17, 2001
- PhRMA Proposes Actual Transaction Price Reimbursement System
September 17, 2001
- Korosho to Conduct Surveys on Terminal Care in FY2002
September 17, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 17, 2001
- WORLD NEWS IN BRIEF
September 17, 2001
- METI Recommends Modernization of Trade Practices in Japan
September 17, 2001
- Kureha, Sankyo to Codevelop Kremezin in US
September 17, 2001
- BULLETIN
September 17, 2001
- Wholesalers Should Charge for Immediate PMS Services: Mr Masuda of Kuraya Sanseido
September 17, 2001
- OTC NEWS IN BRIEF
September 17, 2001
- BUSINESS NEWS IN BRIEF
September 17, 2001
- Cholesterol Levels in Postmenopausal Women to Be Surveyed
September 17, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
September 17, 2001
- DIAGNOSTIC NEWS IN BRIEF
September 17, 2001
- Healthcare Reform: 30% Copayment for the Insured to Be Focused on
September 17, 2001
- Thorough Quality Control for Imported Medical Devices Called For by PMSB
September 17, 2001
- Hodanren Opposes Raising the Age Limit to 75 for Elderly Healthcare Services
September 17, 2001
- PMSB Budget Related to Medical Devices Focuses on Quality, Prioritization of Review
September 17, 2001
- 3 New Drugs Including Biapenem Recommended for Approval
September 17, 2001
- Enforcement of US/EC MRA Expected to Be Delayed: FDA Officer
September 17, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…